PARIS (Reuters) - French pharmaceutical group Sanofi (PA:SASY) is set to start …
All of the shares of common stock to be sold in the offering are to be offered by ... Debiopharm, Lilly, Novartis, Sanofi and Takeda. Kadcyla [®] is a registered trademark of Genentech, a member of the Roche Group. This press release …
However, the drug will face competition from Sanofi’s SNY Synvisc-One, which is also approved for long-term pain relief in patients with OA of knee. Osteoarthritis …
ImmunoGen, Inc. (NASDAQ: IMGN) today announced the closing of its previously announced underwritten public …
Paris, France and Tarrytown, N.Y. - October 16, 2017 - Sanofi and Regeneron Pharmaceuticals, Inc. today announced …
Goldman Sachs initiated the shares of SNY in report on Monday, November 7 with “Neutral” rating. JP Morgan upgraded …
Hargreaves Lansdown may not share ShareCast's (powered by Digital Look) views. (ShareCast News) - French drugmaker Sanofi said it was investing €170m in effort to expand a vaccine manufacturing site in Val de Reuil, located in France, …
KARACHI – The Pakistan Stock Exchange was bearish on Thursday ... Unilever Foods XD recorded the maximum increase in its share price, which was 240.00 …
Stock movers: Shares of General Mills Inc.(GIS ... soared 40% after positive results in a late-stage trial (http://www.marketwatch.com/story/sanofi-alnylam-report-positive-results-from-late-stage-trial-of-hattr-amyloidosis …